117 related articles for article (PubMed ID: 2897118)
1. Anticataleptic effect of taurine: interaction with antiparkinsonian agents.
Zebrowska-Lupina I; Porowska A
Pol J Pharmacol Pharm; 1987; 39(4):329-35. PubMed ID: 2897118
[TBL] [Abstract][Full Text] [Related]
2. Interaction of antidepressants with antiparkinsonian agents in rats.
Zebrowska-Lupina I; Porowska A; Pietrasiewicz T
Pol J Pharmacol Pharm; 1985; 37(6):865-74. PubMed ID: 3832020
[TBL] [Abstract][Full Text] [Related]
3. The effect of antihistaminics on cataleptogenic action of analgesics and haloperidol.
Malec D; Langwiński R
Pol J Pharmacol Pharm; 1983; 35(4):293-300. PubMed ID: 6141553
[TBL] [Abstract][Full Text] [Related]
4. Effect of serotonergic agents on neuroleptic induced catalepsy in rats.
Rao SG; Hrishikeshavan HJ; Guruswami MN
Funct Neurol; 1990; 5(4):353-60. PubMed ID: 1982664
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
[TBL] [Abstract][Full Text] [Related]
6. Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
Kleven MS; Barret-Grévoz C; Bruins Slot L; Newman-Tancredi A
Neuropharmacology; 2005 Aug; 49(2):135-43. PubMed ID: 15996562
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of cataleptogenic effects of neuroleptics by prostaglandins.
Herman ZS; Słomińska-Zurek J; Kryk A; Kmieciak-Kołada K
Pol J Pharmacol Pharm; 1978; 30(5):639-46. PubMed ID: 35782
[TBL] [Abstract][Full Text] [Related]
8. [The action of neuroleptics on different types of catalepsy in rats with a genetic predisposition to catatonic reactions].
Kolpakov VG; Nikulina EM; Alekhina TA; Gevorgian MM
Zh Vyssh Nerv Deiat Im I P Pavlova; 1995; 45(2):388-94. PubMed ID: 7597835
[TBL] [Abstract][Full Text] [Related]
9. [Effect of M3-choline receptor blockade on the ability of muscarinic antagonists to prevent catalepsy induced by haloperidol in rats].
Kosmachev AB; Beliaev VA; Khrabrova AV; Libman NM; Dolgo-Saburov VB
Eksp Klin Farmakol; 2001; 64(4):10-2. PubMed ID: 11589099
[TBL] [Abstract][Full Text] [Related]
10. Haloperidol-induced catalepsy is influenced by calcium channel antagonists.
Biała G
Acta Pol Pharm; 2000; 57(3):233-7. PubMed ID: 11143713
[TBL] [Abstract][Full Text] [Related]
11. Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy.
Maj J; Sowińska H; Baran L
Arch Immunol Ther Exp (Warsz); 1976; 24(2):197-203. PubMed ID: 945050
[TBL] [Abstract][Full Text] [Related]
12. [The effect of selective m-cholinopositive substances on the antiparkinson activity of atropine].
Khrabrova AV; Kosmachev AB; Titkova TA; Chigarev AG
Eksp Klin Farmakol; 1999; 62(4):7-8. PubMed ID: 10513326
[TBL] [Abstract][Full Text] [Related]
13. The influence of antineoplaston A5 on particular subtypes of central dopaminergic receptors.
Juszkiewicz M; Chodkowska A; Burzynski SR; Mlynarczyk M; Kleinrok Z
Drugs Exp Clin Res; 1995; 21(4):153-6. PubMed ID: 8529528
[TBL] [Abstract][Full Text] [Related]
14. Catalepsy produced by long-acting neuroleptics, fluphenazine enanthate and fluphenazine decanoate, in mice.
Yamada K; Furukawa T
Pharmacology; 1982; 24(3):147-55. PubMed ID: 7200248
[TBL] [Abstract][Full Text] [Related]
15. [The role of the genotype in the cataleptogenic effect of neuroleptics].
Skrinskaia IuA; Nikulina EM; Popova NK
Eksp Klin Farmakol; 1992; 55(6):7-9. PubMed ID: 1363957
[TBL] [Abstract][Full Text] [Related]
16. Antiparkinsonian actions of CP-101,606, an antagonist of NR2B subunit-containing N-methyl-d-aspartate receptors.
Steece-Collier K; Chambers LK; Jaw-Tsai SS; Menniti FS; Greenamyre JT
Exp Neurol; 2000 May; 163(1):239-43. PubMed ID: 10785463
[TBL] [Abstract][Full Text] [Related]
17. Prefrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat.
Lipska BK; Jaskiw GE; Braun AR; Weinberger DR
Biol Psychiatry; 1995 Aug; 38(4):255-62. PubMed ID: 8547448
[TBL] [Abstract][Full Text] [Related]
18. MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats.
Ossowska K; Konieczny J; Wolfarth S; Pilc A
Neuropharmacology; 2005 Sep; 49(4):447-55. PubMed ID: 15919101
[TBL] [Abstract][Full Text] [Related]
19. Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens.
Ohno Y; Shimizu S; Imaki J; Ishihara S; Sofue N; Sasa M; Kawai Y
Neuropharmacology; 2008 Oct; 55(5):717-23. PubMed ID: 18585397
[TBL] [Abstract][Full Text] [Related]
20. Central action of narcotic analgesics. VIII. The effect of dopaminergic stimulants on the action of analgesics in rats.
Malec D; Langwiński R
Pol J Pharmacol Pharm; 1981 Oct; 33(3):273-82. PubMed ID: 6119681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
